Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Researchers at the University of Cologne found that mitochondrial dysfunction leads to early skeletal aging by disrupting ...

At ESCMID 2025, early data suggest that Assembly Biosciences’ ABI-5366 could redefine the treatment landscape for recurrent genital herpes (RGH).

Certain DNA sequences can form structures other than the canonical double helix. These alternative DNA conformations—referred ...

Certain DNA sequences can form structures other than the canonical double helix. These alternative DNA conformations - ...

The €500 million deal is Tessellate's first with a pharmaceutical company and focuses on advancing synthetic lethality therapies.

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Engineers and biologists at Dartmouth College have found that, just like word order affects meaning in a sentence, the ...

Before cells divide, they replicate the double-stranded DNA of each chromosome. The replication machinery does a good job of copying the nucleotide sequences until it gets to the telomeres, the end ...

For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial DNA replication, is noninferior to ceftriaxone plus azithromycin, according to a study published online April 14 in The ...